4 Analysts Have This to Say About Xenon Pharmaceuticals

Within the last quarter, Xenon Pharmaceuticals (NASDAQ:XENE) has observed the following analyst ratings: According to 4 analyst offering 12-month price targets in the last 3 months, Xenon Pharmaceuticals has an average price target of $54.0 with a high…

Expert Ratings for Southern

Southern (NYSE:SO) has observed the following analyst ratings within the last quarter: These 8 analysts have an average price target of $71.88 versus the current price of Southern at $71.12, implying upside. Below is a summary of how these 8 analysts r…